Immuneering IMRX
NASDAQ IMRX
$3.73 -0.08 (-2.10%)
At close: Oct 23, 2026 · 4:00 PM EDT

Immuneering (IMRX) Cost of Revenue (2020 - 2022)

Updated

Immuneering (IMRX) posted Cost of Revenue of $158,122 for FY2022, down 86.3% from $1.15 million in FY2021.

Analysis

Immuneering (IMRX) Cost of Revenue (2020 - 2022) Analysis & Trends

  • Business Quant data shows IMRX's Cost of Revenue at $1.15 million in FY2021 (-9.9%) and $1.28 million in FY2020.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cost of Rev (Qtr)
1 Eli Lilly 1,199.50 Bn 1,168.08 Bn 19.71 Bn 3.27 Bn
2 Johnson & Johnson 635.17 Bn 555.03 Bn 17.30 Bn 8.10 Bn
3 AbbVie 504.69 Bn 477.85 Bn 12.70 Bn 4.29 Bn
4 Merck 358.43 Bn 312.86 Bn 12.21 Bn 4.40 Bn
5 Novartis Ag 288.36 Bn 252.75 Bn 11.24 Bn 3.71 Bn
6 Astrazeneca 265.78 Bn 239.54 Bn 12.86 Bn 2.52 Bn
7 Amgen 237.46 Bn 192.86 Bn 7.24 Bn 2.81 Bn
8 Gilead Sciences 193.65 Bn 167.76 Bn 6.22 Bn 1.58 Bn
9 Pfizer 171.05 Bn 118.00 Bn 10.94 Bn 4.09 Bn
10 Immuneering 241.32 Mn -465.67 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2022 19,343.00
Jun 30, 2022 47,933.00
Mar 31, 2022 90,846.00
Dec 31, 2021 206,221.00
Sep 30, 2021 219,088.00
Jun 30, 2021 318,601.00
Mar 31, 2021 409,163.00
Dec 31, 2020 473,233.00
Sep 30, 2020 315,002.00
Jun 30, 2020 237,062.00
API Access

Immuneering Cost of Revenue API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=cost-of-revenue&ticker=IMRX&period=max&api_key=YOUR_API_KEY